^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    Wren Laboratories

    i
    Other names: Wren Laboratories | Wren Laboratories LLC | Wren Laboratories, LLC | Wren Laboratories (Europe) Limited
    Related tests:
    Evidence

    News

    1year
    Wren Laboratories’ new molecular diagnostic predicts patient response to Peptide Receptor Radionuclide Therapy with unprecedented accuracy (BioSpace)
    "Wren’s PPQ, a companion test to Wren Laboratories’ NETest®, classifies patients as either a 'Responder' who will experience disease stabilization and have a longer time to disease progression (usually greater than 18 months after the end of PRRT treatment), or as a 'Non-responder,' who will have a shorter time until the disease progresses (usually less than 12 months after the start of PRRT)."
    Clinical data
    |
    NETest®
    over1year
    Wren Laboratories inks China distribution agreement for neuroendocrine tumor assay (Genomeweb)
    "Wren Laboratories announced...that it finalized a distribution agreement with Kindstar Globalgene Technology to distribute Wren's blood-based neuroendocrine tumor NETest throughout China...Under the five-year agreement, Kindstar Global plans to conduct a pilot study at Peking Union Medical College and use the data in a nationwide educational campaign about the benefits and diagnostic efficacies of the NETest."
    Licensing / partnership
    |
    NETest®